Equate Pain and Fever children's acetaminophen oral suspension recalled
Perrigo Company PLC is recalling Equate Pain and Fever children's acetaminophen oral suspension nationwide due to contaminated excipient used in manufacturing that was itself recalled from the supplier.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard—contaminated excipient—is identified but theoretical, and the source text does not specify the nature or risk profile of the contamination itself, making this a precautionary manufacturing-related recall.
Plain-English summary
Perrigo Company PLC is recalling Equate Pain and Fever Children's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml) distributed by Walmart, Inc. The product was manufactured using a contaminated excipient that had been recalled by the excipient supplier. The affected product includes bottles with batch numbers 1BK0962 (expiration 12/31/2022) and 1CK0999 (expiration 01/31/2023), with a total of 111,888 bottles distributed nationwide in the USA.
Consumers who have purchased this product should stop using it and contact their healthcare provider if they have any concerns about whether they or their child has consumed it.
The recalled product
- Product
- EQUATE PAIN AND FEVER (ACETAMINOPHEN)
- Brand
- EQUATE PAIN AND FEVER
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batch: 1BK0962
- Exp 12/31/2022
- 1CK0999
- Exp 01/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · EQUATE PAIN AND FEVER
- ModerateEquate Infant Pain and Fever Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27